These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16843774)

  • 1. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
    McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
    Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients.
    Benharash P; Bongard F; Putnam B
    Am Surg; 2005 Sep; 71(9):776-80. PubMed ID: 16468517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant factor VIIa improves coagulopathy caused by liver failure.
    Brown JB; Emerick KM; Brown DL; Whitington PF; Alonso EM
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):268-72. PubMed ID: 12960648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
    Martinowitz U; Holcomb JB; Pusateri AE; Stein M; Onaca N; Freidman M; Macaitis JM; Castel D; Hedner U; Hess JR
    J Trauma; 2001 Apr; 50(4):721-9. PubMed ID: 11303171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
    Martinowitz U; Kenet G; Segal E; Luboshitz J; Lubetsky A; Ingerslev J; Lynn M
    J Trauma; 2001 Sep; 51(3):431-8; discussion 438-9. PubMed ID: 11535886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy.
    Gowers CJ; Parr MJ
    Anaesth Intensive Care; 2005 Apr; 33(2):196-200. PubMed ID: 15960401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
    Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
    Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseases.
    Mathew P; Winter SS; Frost JD; Hanrahan J; Schwartz M; Jones JE
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):499-502. PubMed ID: 12794532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage.
    Khan AZ; Parry JM; Crowley WF; McAllen K; Davis AT; Bonnell BW; Hoogeboom JE
    Am J Surg; 2005 Mar; 189(3):331-4. PubMed ID: 15792762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome.
    Ganguly S; Spengel K; Tilzer LL; O'neal B; Simpson SQ
    Clin Lab Haematol; 2006 Oct; 28(5):309-12. PubMed ID: 16999720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.
    Pusateri AE; Park MS
    Crit Care; 2005; 9 Suppl 5(Suppl 5):S15-24. PubMed ID: 16221315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of critical bleeding in trauma patients.
    Chiara O; Cimbanassi S; Brioschi PR; Bucci L; Terzi V; Vesconi S
    Minerva Anestesiol; 2006 Jun; 72(6):383-7. PubMed ID: 16682905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting response to recombinant factor VIIa in non-haemophiliac patients with severe haemorrhage.
    Bowles KM; Callaghan CJ; Taylor AL; Harris RJ; Pettigrew GJ; Baglin TP; Park GR
    Br J Anaesth; 2006 Oct; 97(4):476-81. PubMed ID: 16914465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
    Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
    Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
    Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.